PAVMEDLOGONEW15OCT2018.png
PAVmed Subsidiary Lucid Diagnostics’ EsoCheck Esophageal Cell Collection Device Receives Prestigious Edison Best New Product Award
April 02, 2020 09:30 ET | PAVmed Inc.
NEW YORK, April 02, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that the...
PAVMEDLOGONEW15OCT2018.png
PAVmed Receives $6.3 Million in Gross Proceeds from Completion of November 2019 Financing
March 31, 2020 09:30 ET | PAVmed Inc.
NEW YORK, March 31, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced it has...
PAVMEDLOGONEW15OCT2018.png
PAVmed to Hold Business Update Conference Call on April 9, 2020
March 24, 2020 09:30 ET | PAVmed Inc.
NEW YORK, March 24, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that the...
PAVMEDLOGONEW15OCT2018.png
PAVmed Announces FDA 510(k) Re-submission for its CarpX™ Minimally Invasive Carpal Tunnel Device
March 09, 2020 09:30 ET | PAVmed Inc.
Incorporates data from successful clinical safety study in which all patients met pre-specified safety and effectiveness endpoints NEW YORK, March 09, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq:...
PAVMEDLOGONEW15OCT2018.png
PAVmed Reports Third Quarter 2019 Financial Results and Provides Business Update
November 21, 2019 16:00 ET | PAVmed Inc.
Conference call to be held on November 21, 2019 at 4:30 p.m. Eastern time NEW YORK, Nov. 21, 2019 (GLOBE NEWSWIRE) --  PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly...
PAVMEDLOGONEW15OCT2018.png
PAVmed Partners with Laser Technology Pioneer Dr. Jacob Wong to Develop and Commercialize Non-Invasive Laser-based Diagnostic Products
November 14, 2019 09:30 ET | PAVmed Inc.
Secures exclusive worldwide license for Nondispersive Infrared (NDIR) laser technology Launches joint development program for NDIR laser-based diagnostic products to measure glucose, electrolytes...
PAVMEDLOGONEW15OCT2018.png
PAVmed Reports Second Quarter 2019 Financial Results and Provides Business Update
September 05, 2019 09:30 ET | PAVmed Inc.
Conference call to be held on September 5, 2019 at 4:30 p.m. Eastern time NEW YORK, Sept. 05, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly...
CarpX™ 510(k)
PAVmed Successfully Completes Clinical Safety Study Procedures for CarpX™ 510(k) Re-submission
August 15, 2019 09:30 ET | PAVmed Inc.
All 20 patients underwent successful CarpX procedures while passing primary effectiveness endpoint, with all follow-up patients to date passing primary safety endpoint NEW YORK, Aug. 15, 2019 ...
PAVMEDLOGONEW15OCT2018.png
PAVmed to Join Russell Microcap® Index
June 26, 2019 09:30 ET | PAVmed Inc.
NEW YORK, June 26, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced the Company...
PortIO™
PAVmed Announces PortIO™ Breakthrough
March 13, 2019 08:04 ET | PAVmed Inc.
Groundbreaking implantable intraosseous vascular access device achieves unprecedented maintenance-free implant duration of over 60 days in pre-clinical testing NEW YORK, March 13, 2019 (GLOBE...